Insulet Corporation
Insulet Corporation (PODD) Revenue
Annual & quarterly revenue history · segment & region breakdown
PODD · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsInsulet Corporation trailing twelve-month (TTM) revenue is $2.90B, an increase of 30.73% year-over-year from $2.71B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $2.71B | +$0.64B | +30.73% |
| 2024-12-31 | $2.07B | +$0.37B | +22.07% |
| 2023-12-31 | $1.70B | +$0.39B | +30.02% |
| 2022-12-31 | $1.31B | +$0.21B | +18.79% |
| 2021-12-31 | $1.10B | +$0.19B | +21.49% |
| 2020-12-31 | $0.90B | +$0.17B | +22.51% |
| 2019-12-31 | $0.74B | +$0.17B | +30.93% |
| 2018-12-31 | $0.56B | +$0.10B | +21.57% |
| 2017-12-31 | $0.46B | +$0.10B | +26.37% |
| 2016-12-31 | $0.37B | +$0.10B | +39.07% |
Compare revenue vs peers
Medical - DevicesCompare PODD revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Insulet Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Insulet Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Insulet Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PODD revenue · 4 questionsPODD's trailing twelve-month (TTM) revenue is $2.90B. That is an increase of 30.73% year-over-year from $2.71B in FY2025.
▸ Source: FMP · Insulet Corporation SEC filings · GAAP · Insulet Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026